DHEA Complete provides both bioidentical DHEA and the more targeted 7-Keto® DHEA metabolite. The 7-Keto® DHEA form has been shown to safely increase thermogenesis, and help maintain healthy body weight and body fat when combined with a diet and exercise program.17-19 A clinical study indicated that 7-Keto® DHEA increases the resting metabolic rate of adults.20 Antioxidants are added based on the effect 7-Keto® has in boosting mitochondrial oxidation.
It has been shown that the serum hormone DHEA often declines by 75%–80% from peak levels by age 70, leading to hormonal imbalances that can affect one’s quality of life.1-4 Peak blood levels of DHEA occur at approximately age 25, decreasing progressively thereafter.3 The marked decline in serum DHEA with age is believed to play a role in health problems associated with aging. Thus, scientists have been looking at ways of restoring DHEA to youthful levels to prevent or reverse those health issues, and are now discovering mechanisms by which DHEA protects against age-related decline.
Since 1981, several thousand studies have been published on DHEA’s various benefits, including immunomodulatory properties as well as positive effects on mood, quality of life, and body composition. It has been proposed that restoring the circulating levels of DHEA to those found in young people may improve well-being and sexual function. In a randomized, double-blind, placebo-controlled study, ten months of DHEA replacement therapy showed a beneficial effect of enhancing the increases in muscle mass and strength with the addition of resistance exercise in elderly individuals.4 The studies of DHEA therapy in women with adrenal insufficiency also suggest beneficial effects on well-being, mood, and sexuality.5 DHEA could be of benefit to the normal aging brain.6-8 Some studies have reported DHEA may improve mood and alleviate melancholy.9 In addition, recent studies have shown that DHEA has the capacity to improve vascular health by a number of complex processes.10-12 One of them is increasing nitric oxide synthesis.10
In a randomized, double-blind, controlled trial, DHEA replacement therapy for one year helped protect hip bone mineral density in older adults and spine bone mineral density in older women.13 DHEA has also been shown to support a healthy circulatory system and joint/bone health.10-12,14,15
DHEA usage and safety precautions
Life Extension has been investigating DHEA for over 30 years. Life Extension’s DHEA directions for use are specially drafted to provide optimal, but safe dosing.
The standard blood test to evaluate DHEA status is one that measures DHEA sulfate levels (dehydroepiandrosterone sulfate or DHEA-S). The DHEA-S is calculated in micrograms per deciliter (µg/dL) of blood. A DHEA-S blood test may be taken three to six weeks after initiating a DHEA supplementation regimen to help determine optimal dosing. DHEA testing may save you money if it shows you can take less DHEA to maintain youthful DHEA serum levels.
Because of the overwhelming evidence connecting low levels of DHEA to problems associated with aging, Life Extension suggests that all people over age 40 begin DHEA therapy. For most people, the starting dose of DHEA is between 15–75 mg, taken in one daily dose. Many studies have used a daily dose of 50 mg.
Since almost everyone over age 35–40 has lower than optimal levels of DHEA, most people begin supplementation ... and then test their blood DHEA levels later to make sure they are taking the proper dose. Normal serum reference ranges and ideal ranges of DHEA-S are:
|
Normal
(depending on age)
|
Ideal
|
| Men |
16.2-492 µg/dL
|
350-490 µg/dL
|
| Women |
12-407 µg/dL
|
275-400 µg/dL
|
People over age 40 who do not supplement with DHEA usually have serum levels below 200 µg/dL, and many are below 100 µg/dL since a steady decline takes place after the third decade in life.1,16
There are different precautions for men and women that should be observed.
DHEA precautions for men
Before attempting to restore DHEA to youthful levels, men should know their serum PSA (prostate specific antigen) level. Men with prostate cancer or severe benign prostate disease are advised to avoid DHEA since it can be converted into testosterone (and estrogen). Therefore, men are advised to have a PSA and digital rectal exam before initiating DHEA to rule out existing prostate disease.
When taking DHEA we also recommend taking the following other nutrients daily:
| Vitamin D | 5,000 – 10,000 IU |
Vitamin E
(D-alpha tocopheryl succinate) | 400 IU |
| Selenium | 200 mcg |
Gamma E Tocopherol
with Sesame Lignans | 200 mg |
| Lycopene Extract | 10 – 40 mg |
| Boron | 3 – 10 mg |
Cruciferous Vegetable Extracts
(as found in Triple Action Cruciferous Vegetable Extract) | 500 – 1000 mg |
It is important for men over 40 to have a physician check their PSA and DHEA-S serum levels every six to twelve months thereafter. Men should also periodically check their blood levels for free testosterone and estrogen to make sure that DHEA is following a youthful metabolic pathway.
See the Male Hormone Restoration protocol or the Male Hormone Modulation chapter in the Disease Prevention & Treatment book for additional hormone balance testing that can be done at the same time serum DHEA-S and PSA levels are being tested.
DHEA precautions for women
Women should consider estrogen and testosterone testing when they take their DHEA blood test in order to evaluate DHEA’s effect on their blood levels of these hormones.
Women who have been diagnosed with an estrogen-dependent cancer should consult their physicians before beginning the DHEA restoration process.
When taking DHEA we also recommend taking the following other nutrients to maintain a healthy balance each day:
| Melatonin | 300 mcg – 3 mg (nightly) |
Vitamin E
(D-alpha tocopheryl succinate) | 400 IU |
Broccoli Extract
(as found in Triple Action Cruciferous Vegetable Extract) | 400 mg |
Indole-3-carbinol
(as found in Triple Action Cruciferous Vegetable Extract) | 80 – 160 mg |
| Vitamin D3 | 5,000 – 10,000 IU |
Gamma Tocopherol
with Sesame Lignans | 200 mg |
Women taking DHEA should refer to the Female Hormone Restoration protocol or the Female Hormone Modulation chapter in the Disease Prevention & Treatment book for information about restoring youthful hormone balance.
This supplement should be taken in conjunction with a healthy diet and regular exercise program. Results may vary.
| Supplement Facts |
| Serving Size 1 vegetarian capsule |
| Servings Per Container 60 |
| Amount Per Serving |
| Vitamin C (as ascorbyl palmitate) | 11 mg |
| 7-Keto® DHEA (3-acetyl-7-oxo-dehydroepiandrosterone) | 100 mg |
| Ascorbyl palmitate | 25 mg |
| BCM-95® Bio-Curcumin® (Curcuma longa) 25:1 extract (root) [std. to 95% Total Curcuminoids Complex with Essential Oils of Turmeric Rhizome by HPLC (23.75 mg)] | 25 mg |
| DHEA (dehydroepiandrosterone) | 25 mg |
| Green tea (Camellia sinensis) decaffeinated extract (leaf) [Standardized to 98% polyphenols (24.5 mg)] | 25 mg |
| Polygonum cuspidatum (root) and whole red grape (Vitis vinifera) extracts [std. to 35% trans-resveratrol (1 mg)] | 3 mg |
| Other ingredients: rice flour, vegetable cellulose (capsule), vegetable stearate. |
| Contains rice. |
7-Keto® is a registered trademark of Humanetics Corporation.
Bio-Curcumin® and BCM-95® are registered trademarks of Dolcas-Biotech, LLC. U.S. Patent Nos. 7,883,728, 7,736,679 and 7,879,373.
|
| Dosage and Use |
- Take one capsule upon waking and one capsule before midday meal, preferably on an empty stomach or as recommended by a healthcare practitioner.
|
| Caution |
Do not use DHEA if you are at risk for or have been diagnosed as having any type of hormonal cancer, such as prostate or breast cancer.
Hormones
1. J Clin Endocrinol Metab. 1992 Oct;75(4):1002-4.
2. J Clin Endocrinol Metab. 1997 Aug;82(8):2396-402.
3. Clin Chim Acta. 2004 Mar;341(1-2):1-15.
4. Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1003-8.
5. Maturitas.2010 Jun;66(2):172-9.
6. Front Neuroendocrinol.2009 Jan;30(1):65-91.
7. Biogerontology. 2008 Aug;9(4):235-46.
8. Ann N Y Acad Sci. 2006 Nov;1088:139-52.
9. Psychopharmacology (Berl). 2006 Nov;188(4):541-51.
10. Pharmacol Ther. 2010 May;126(2):186-99.
11. Circulation. 2009 Sep 29;120(13):1231-40
12. Atherosclerosis. 2009 Sep;206(1):77-85.
13. J Clin Endocrinol Metab. 2006 Aug;91(8):2986-93
14. Clin Endocrinol (Oxf). 2006 Mar;64(3):260-4
15. Clin Chim Acta.2009 Oct;408(1-2):1-7.
16. J Endocrinol. 1999 Oct;163(1):1-5.
17. Curr Ther Res. 2000;61(7):435-42.
18. Arch Biochem Biophys. 1997 May 1;341(1):122-8.
19. Curr Ther Res; 2002;63(4):263-72
20. J Nutr Biochem. 2007 Sep;18(9):629-34.
21. Steroids. 2000 Mar;65(3):124-9.
22. Steroids. 2009 Nov;74(12):931-7.
23. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12308-12.
24. Psychiatry Res. 2010 Jul 30;178(2):309-12.
25. Prog Brain Res. 2010;186:113-37.
26. Circ Res. 2010 May 14;106(9):1507-15.
27. CNS Neurosci Ther. 2010 Spring;16(1):32-44.
28. Neuropsychopharmacology. 2009 Jul;34(8):1885-903.
29. Neurochem Int. 2008 Mar-Apr;52(4-5):522-40.
30. Psychoneuroendocrinology. 2008 Feb;33(2):214-26.
31. Eur J Med Chem. 2009 Jul;44(7):2944-51.
32. Horm Metab Res. 1998 Jan;30(1):16-28.
33. J Clin Endocrinol Metab. 2002 Feb;87(2):589-98.
34. J Clin Endocrinol Metab. 2002 Aug;87(8):3632-9.
35. Science. 1984 Sep 7:225(4666):1032-4.
36. Altern Med Rev. 2007 Sep;12(3):280-4
37. Presented at the First International Congress on Ethnopharmacology, Strasbourg, France. 1990;June 5-9.
38. Ethnopharmacology. 1995 Mar. Dr Waynberg
39. Eur J Cancer Prev. 2002;11(Suppl 2):S48-57.
40. Br J Nutr. 2007 Aug;98(2):388-96.
41. Cancer Causes Control. 2006 Mar;17(2):169-80.
42.J Womens Health (Larchmt). 2010 Feb;19(2):209-18
43. J Alt Complement Med. 1998;4(3):289-303.
44. Menopause. 2008 Nov-Dec;15(6):1157-62.
45. Phytother Res. 2012 Apr;26(4):510-6
46. Phytomedicine. 2010 May;17(6):389-96.
47. Maturitas. 2006 May 20;54(2):164-75.
48. Udani J, Hardy M. The effect of HMRlignan on mammalian lignan and estrogen metabolite levels in post-menopausal women: A randomized, double-blind, single dummy, parallel group, pilot study. Nov 6, 2007
49. J Steroid Biochem Mol Biol. 2007 Nov-Dec;107(3-5):140-8
50. Am J Clin Nutr. 2010 Jul;92(1):141-53.
52. Best Pract Res Clin Obstet Gynaecol. 2009 Feb;23(1):7-23.
53. Climacteric. 2009;12 Suppl 1:47-51.
54. J Sex Med. 2010 Jan;7(1 Pt 2):561-85.
55. Ann N Y Acad Sci. 2010 Aug;1204:179-87.
56. Sports Med. 2010 Jan 1;40(1):41-58.
57. Cell Mol Immunol. 2009 Aug;6(4):277-83.
58. Med Pregl. 2009;62 Suppl 3:85-90.
59. J Clin Endocrinol Metab. 2010 Aug;95(8):3569-77.
60. Altern Ther Health Med. 2001 May-Jun;7(3):93-100.
61. J Womens Health Gend Based Med. 2002 Mar;11(2):163-74.
62. J Womens Health. 1998 Jun;7(5):525-9.
63. J Steroid Biochem Mol Biol. 2004 Jul;91(3):147-55.
64. Clin Cancer Res. 2007 Feb 1;13(3):1061-7.
65. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):339-44.
66. Cancer Causes Control. 2004 Oct;15(8):805-18.
67. Int J Cancer. 2004 Sep 1;111(3):440-3.
68. Int J Oncol. 2008 Oct;33(4):657-63.
69. Carcinogenesis. 2006 Apr;27(4):782-90.
70. Food Chem Toxicol. 2008 Jul;46(7):2358-64.
71. World Scientific, 1986:489-505.
72. Maturitas. 2009 May 20;63(1):99-103.
73. Nat Prod Res. 2008 Apr 15;22(6):537-46.
74. Arzneimittelforschung. 1993 Jul;43(7):752-6.
75. Ceska Gynekol. 1998 Oct;63(5):388-92.
76. J Agric Food Chem. 2006 Nov 15;54(23):8956-61.
77. J Agric Food Chem. 2008 Feb 27; 56(4): 1415-22.
78. J Agric Food Chem. 2007 Nov 28;55(24):10050-4
79. Nutr Res. 2008 Feb;28(2):72-7.
80. Atherosclerosis. 2001 Sep;158(1):195-8.
81. Clin Nutr. 2004 Jun;23(3):423-33
82. Exp Gerontol. 2001 Jul;36(7):1083-100.
83. J Pineal Res. 1994 May;16(4):178-83.
84. J Pineal Res. 2011 Jan;50(1):1-7.
85. Bull Acad Natl Med. 2011 Oct;195(7):1527-46; discussion 1547-9.
86. Curr Med Chem. 2012;19(21):3508-22.
87. Free Radic Res. 2002 Dec;36(12):1323-9.
88. J Endocrinol. 1981 Dec;91(3):467-75.
89. Surg Today. 2003;33(12):896-901.
90. J Oral Implantol. 2012 Apr 16. [Epub ahead of print]
91. J Pineal Res. 2012 Oct;53(3):270-8.
92. Recent Pat Endocr Metab Immune Drug Discov. 2011 May;5(2):100-8.
93. J Physiol Pharmacol. 2011 Oct;62(5):521-6.
94. J Pineal Res. 2012 Jan;52(1):62-70.
95. Maturitas. 2002 Apr 15;41 Suppl 1:S85-104.
96. Chronobiol Int. 2000 May;17(3):419-32.
97. Aging (Milano). Oct1995;7(5):340-51.
98. J Endocrinol Invest. 2006 Mar;29(3):281-7.
99. Sleep. 1996 Jun;19(5):423-31.
100. Clin Pharmacol Ther. 1995 May;57(5):552-8.
101. Actas Esp Psiquiatr. 2000 Sep-Oct;28(5):325-9.
102. J Clin Psychiatry. 2007 Feb;68(2):237-41.
103. Available at: http://emedicine.medscape.com/article/126999-overview. Accessed March 21, 2013
104. Proc Soc Exp Biol Med. 1990 Apr;193(4):301-5.
105. J Sports Med Phys Fitness. 1989 Mar;29(1):52-6.
106. J Strength Cond Res. 2010 Apr;24(4):1082-90.
107. Curr Opin Clin Nutr Metab Care. 2008 Jan;11(1):50-4.
108. Nutr Neurosci. 2003 Oct;6(5):269-75.
|
|
